Global Nocturia Market Growth (Status and Outlook) 2023-2029

Global Nocturia Market Growth (Status and Outlook) 2023-2029

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
LPI (LP Information)' newest research report, the “Nocturia Industry Forecast” looks at past sales and reviews total world Nocturia sales in 2022, providing a comprehensive analysis by region and market sector of projected Nocturia sales for 2023 through 2029. With Nocturia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nocturia industry.
This Insight Report provides a comprehensive analysis of the global Nocturia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nocturia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nocturia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nocturia and breaks down the forecast by type, by sale channels, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nocturia.
The global Nocturia market size is projected to grow from US$ 2090.1 million in 2022 to US$ 3407.2 million in 2029; it is expected to grow at a CAGR of 7.2% from 2023 to 2029.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report presents a comprehensive overview, market shares, and growth opportunities of Nocturia market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Segmentation by sale channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical

Please note: The report will take approximately 2 business days to prepare and deliver.